DCE MRI plays a critical role in routine clinical breast examination. Current work focuses on the development of Breast DCE MRI phantom using a 3D printer to mimic poor and well perfused regions. The phantom developed was controlled through user entered Ktrans values entered in a GUI which interfaced with a peristaltic pump to control flow rates. The Kep parameters was controlled through the 3D model geometry. Prospective MR images of the phantom were acquired on a 1.5T scanner using the TRICKS sequence; and pharmacokinetic maps based on Tofts model were computed and quantified.
Methods and Materials
A Breast DCE-MRI phantom was designed using Dimension Dual Delta 3D printer (J Robotics Pvt Ltd). Fig. 1 shows the diagram of phantom printed (A, B). Top part in Fig.1a was downloaded from ref1 and was printed to mimic breast morphology. The bottom part in Fig.1b consists of tumour mimicking geometry design which was designed using 123d Autodesk® software. This consisted of the two cylinders as shown in Fig. 1(d). These cylinders enabled the control of the wash-out characteristics. Fig. 1 depicts the phantom parts along with dimensions. The phantom was connected to a peristaltic pump and water reservoirs. The top part of the phantom was filled with 2% agar solution to mimic tissue (w/v). These connections and the setup is shown in Fig 2. Tap water was continuously pumped into the phantom using the pump which was controlled via user entered Ktrans values in Matlab (the Mathworks Inc) GUI, Ktrans values of 1.5 min-1 (inner cylinder) and 0.5 min-1 (outer cylinder) were entered. These values were employed to calculate the flow rate (ml/min) to be pumped from the peristaltic pump (e.g.1.5 ml/s * 60=90 ml/min). Kep values were controlled through: the inner ring was designed in such way that CA and water filling inside the inner cylinder took more time to discharge due to the increased depth. CuSO4 of six different concentrations (shown in Fig. 3) were prepared and T1 maps were determined using the variable flip angle method (TR=6.8/6.8/6.7/6.9/7.1/7.3 ms, FA=2/10/20/30/45/60). R1 as a function of concentration was plotted and slope of the line was calculated to determine the relaxivity of Contrast Agent (CA). CuSO4 of 6 mmol concentration was employed as CA. Phantom experiments were conducted on a 1.5T GE SIgna scanner. Images were acquired using TRICKS sequence2 with parameters of TR/TE= 6.088/2.296, FA=20, number of frames=100 with temporal resolution of 6s. CA was injected after 1/2 min. Concentration time curves were calculated from the obtained signal intensity images and were analyzed by the two compartmental Tofts model to determine the pharmacokinetic maps.[1] https://uwcem.ece.wisc.edu/phantomRepository.html
[2] Petkova et al. JMRI 2009
Figure 5 a) The Pharmacokinetic maps obtained from Tofts model b) Concentration time curves for three different ROI drawn in the image c) Signal intensity image of Breast DCE MRI phantom from different view
*Note: Y axes representing concentration time curves are different for the three plots